Florence Acquires Zipnosis to Solve Clinical Capacity Constraints and Create Omnichannel Transformation Across Telehealth and Hybrid Care
24 May 2023
Acquisition
Following its official launch last month, the health tech company is adding Zipnosis' technology to its suite of offerings to build a modern, more accessible and efficient healthcare experience for clinicians and patients
NEW YORK, May 24, 2023 /PRNewswire/ -- Florence, an innovator in healthcare enablement software, announced today its acquisition of Zipnosis, an asynchronous-first virtual care solution that creates efficiency for clinicians while making quality care more accessible and affordable for patients.
Through this acquisition, Florence will broaden its product offerings with synchronous and asynchronous virtual care and further their mission to create a consumer-centric interface that engages patients at every stage of their journey across virtual and physical care to solve healthcare's most significant constraint: clinical capacity.
"Zipnosis' asynchronous telemedicine solution is the best in the industry and perfectly aligns with Florence's vision to create capacity to care in physical settings," said Aniq Rahman, CEO of Florence. "Together, we'll create exceptional healthcare experiences for patients virtually and in-clinic while freeing up time for clinicians to focus on what they do best, care for patients."
Adding to Florence's already robust platform, Zipnosis boosts patient accessibility and frees up 99% of provider work time by using intelligent adaptive interviews that enable care delivery in just 89 seconds. As a result, physicians are able to treat more patients while allocating additional time to those with greater needs. Zipnosis has facilitated 4.5 million patient encounters and engaged 3,500 physicians at over 50 different top health institutions, including Ballad Health, SSM Health, the Medical University of South Carolina, and Allina Health.
The acquisition follows Florence's formal launch last month, at which time the company announced $20 million in seed funding led by Thrive Capital, GV (Google Ventures), and Salesforce Ventures. With Florence, patients benefit from an experience that rivals consumer-focused industries with the ability to track and accelerate their healthcare journey via smartphone, update clinical information, facilitate prescription fulfillment, initiate self-discharge and schedule follow-up appointments. Florence is dedicated to developing products across multiple sites of care to boost patient satisfaction, increase clinical capacity and reduce rates of patients leaving without being seen by enabling health systems to create omnichannel transformation across telehealth and hybrid care in sites like the emergency room and beyond.
About Florence (Florence Labs, Inc.)
Florence is a health tech company that creates solutions to healthcare's biggest constraint: clinical capacity. Florence's technology enables healthcare providers to deliver faster, higher quality and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff. To learn more, visit www.florenceos.com.
About Zipnosis:
Zipnosis, dba of DocSquad LLC, is a 60-person health tech company that offers a white-labeled virtual care solution that uses asynchronous telemedicine to connect patients with local board-certified physicians — anytime, anywhere. By enabling physicians to treat patients 10 times faster than a video visit or in-person care, this technology overcomes the largest constraint in healthcare — provider time — and increases physician capacity by 60% in just 15 minutes per day.
Contact:
Meir Sabbagh
[email protected]
SOURCE Florence Labs, Inc.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.